According to a newly published market research report by 24LifeSciences, global secondary hyperparathyroidism treatment market was valued at USD 3.17 billion in 2024 and is projected to reach USD 4.58 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period 20252031. Secondary hyperparathyroidism is an endocrine disorder characterized by excessive...

According to a new report from Intel Market Research, the global Secondary Market was valued at USD 175 trillion in 2025 and is projected to reach USD 245 trillion by 2034, growing at a robust CAGR of 3.8% during the forecast period (2026–2034). This growth is propelled by surging retail investor participation through mobile apps, rapid digitalization of trading infrastructure, expanding...